Cargando…
COVID-19 in Lymphangioleiomyomatosis: An International Study of Outcomes and Impact of Mechanistic Target of Rapamycin Inhibition
| Autores principales: | , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American College of Chest Physicians. Published by Elsevier Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8687712/ https://www.ncbi.nlm.nih.gov/pubmed/34942174 http://dx.doi.org/10.1016/j.chest.2021.12.640 |
| _version_ | 1784618229175418880 |
|---|---|
| author | Baldi, Bruno Guedes Radzikowska, Elzbieta Cottin, Vincent Dilling, Daniel F. Ataya, Ali Carvalho, Carlos Roberto Ribeiro Harari, Sergio Koslow, Matthew Grutters, Jan C. Inoue, Yoshikazu Gupta, Nishant Johnson, Simon R. |
| author_facet | Baldi, Bruno Guedes Radzikowska, Elzbieta Cottin, Vincent Dilling, Daniel F. Ataya, Ali Carvalho, Carlos Roberto Ribeiro Harari, Sergio Koslow, Matthew Grutters, Jan C. Inoue, Yoshikazu Gupta, Nishant Johnson, Simon R. |
| author_sort | Baldi, Bruno Guedes |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8687712 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | American College of Chest Physicians. Published by Elsevier Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-86877122021-12-21 COVID-19 in Lymphangioleiomyomatosis: An International Study of Outcomes and Impact of Mechanistic Target of Rapamycin Inhibition Baldi, Bruno Guedes Radzikowska, Elzbieta Cottin, Vincent Dilling, Daniel F. Ataya, Ali Carvalho, Carlos Roberto Ribeiro Harari, Sergio Koslow, Matthew Grutters, Jan C. Inoue, Yoshikazu Gupta, Nishant Johnson, Simon R. Chest Diffuse Lung Disease: Research Letters American College of Chest Physicians. Published by Elsevier Inc. 2022-06 2021-12-21 /pmc/articles/PMC8687712/ /pubmed/34942174 http://dx.doi.org/10.1016/j.chest.2021.12.640 Text en © 2021 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Diffuse Lung Disease: Research Letters Baldi, Bruno Guedes Radzikowska, Elzbieta Cottin, Vincent Dilling, Daniel F. Ataya, Ali Carvalho, Carlos Roberto Ribeiro Harari, Sergio Koslow, Matthew Grutters, Jan C. Inoue, Yoshikazu Gupta, Nishant Johnson, Simon R. COVID-19 in Lymphangioleiomyomatosis: An International Study of Outcomes and Impact of Mechanistic Target of Rapamycin Inhibition |
| title | COVID-19 in Lymphangioleiomyomatosis: An International Study of Outcomes and Impact of Mechanistic Target of Rapamycin Inhibition |
| title_full | COVID-19 in Lymphangioleiomyomatosis: An International Study of Outcomes and Impact of Mechanistic Target of Rapamycin Inhibition |
| title_fullStr | COVID-19 in Lymphangioleiomyomatosis: An International Study of Outcomes and Impact of Mechanistic Target of Rapamycin Inhibition |
| title_full_unstemmed | COVID-19 in Lymphangioleiomyomatosis: An International Study of Outcomes and Impact of Mechanistic Target of Rapamycin Inhibition |
| title_short | COVID-19 in Lymphangioleiomyomatosis: An International Study of Outcomes and Impact of Mechanistic Target of Rapamycin Inhibition |
| title_sort | covid-19 in lymphangioleiomyomatosis: an international study of outcomes and impact of mechanistic target of rapamycin inhibition |
| topic | Diffuse Lung Disease: Research Letters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8687712/ https://www.ncbi.nlm.nih.gov/pubmed/34942174 http://dx.doi.org/10.1016/j.chest.2021.12.640 |
| work_keys_str_mv | AT baldibrunoguedes covid19inlymphangioleiomyomatosisaninternationalstudyofoutcomesandimpactofmechanistictargetofrapamycininhibition AT radzikowskaelzbieta covid19inlymphangioleiomyomatosisaninternationalstudyofoutcomesandimpactofmechanistictargetofrapamycininhibition AT cottinvincent covid19inlymphangioleiomyomatosisaninternationalstudyofoutcomesandimpactofmechanistictargetofrapamycininhibition AT dillingdanielf covid19inlymphangioleiomyomatosisaninternationalstudyofoutcomesandimpactofmechanistictargetofrapamycininhibition AT atayaali covid19inlymphangioleiomyomatosisaninternationalstudyofoutcomesandimpactofmechanistictargetofrapamycininhibition AT carvalhocarlosrobertoribeiro covid19inlymphangioleiomyomatosisaninternationalstudyofoutcomesandimpactofmechanistictargetofrapamycininhibition AT hararisergio covid19inlymphangioleiomyomatosisaninternationalstudyofoutcomesandimpactofmechanistictargetofrapamycininhibition AT koslowmatthew covid19inlymphangioleiomyomatosisaninternationalstudyofoutcomesandimpactofmechanistictargetofrapamycininhibition AT gruttersjanc covid19inlymphangioleiomyomatosisaninternationalstudyofoutcomesandimpactofmechanistictargetofrapamycininhibition AT inoueyoshikazu covid19inlymphangioleiomyomatosisaninternationalstudyofoutcomesandimpactofmechanistictargetofrapamycininhibition AT guptanishant covid19inlymphangioleiomyomatosisaninternationalstudyofoutcomesandimpactofmechanistictargetofrapamycininhibition AT johnsonsimonr covid19inlymphangioleiomyomatosisaninternationalstudyofoutcomesandimpactofmechanistictargetofrapamycininhibition |